05

Home >> 2020 >> August >> 05

CRISPR/Cas9-repaired iPSC-cardiomyocytes display a restored function and a normalized muscle contraction.© Cyganek, UMG

05.08.2020

CRISPR/Cas9 – GENE EDITING: New therapeutic approach for congenital heart defects

Scientists at the Heart Center of the University Medical Center Göttingen have for the first time found an approach for a personalised therapy option with “gene editing” for the Noonan Syndrome. Publication in the renowned journal “Circulation“. Link to the press release
Learn More

CRISPR/Cas9-repaired iPSC-cardiomyocytes display a restored function and a normalized muscle contraction.© Cyganek, UMG

05.08.2020

CRISPR/Cas9 – GENE EDITING: New therapeutic approach for congenital heart defects

Scientists at the Heart Center of the University Medical Center Göttingen have for the first time found an approach for a personalised therapy option with “gene editing” for the Noonan Syndrome. Publication in the renowned journal “Circulation“. (umg/ mbexc) Congenital heart diseases are the most common organ defects. They occur
Learn More
X

Open Positions

EN DE
X
X